IGHE and cancer: B cells are known to promote allergy through antigen presentation and class‐switching to IgE, whereas under certain conditions, tumor‐infiltrating B cells can be associated with improved patient survival in cancer.79, 84 In contrast, Breg‐associated immune tolerance can lead to control of allergy or tumor progression in cancer.79